Please complete the CAPTCHA to continue
@roche.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Stephen Wright is listed as Senior Director Global Product Strategy & Franchise Lead for Rheumatology & Nephrology at Roche/Genentech at Roche, based in South San Francisco, California, United States. AeroLeads shows a work email signal at roche.com and a matched LinkedIn profile for Stephen Wright.
Stephen Wright previously worked as Lifecycle Leader | Global Product Strategy Role at Roche and LifeCycle Leader at Roche. Stephen Wright holds Doctor Of Medicine Md, Medicine from Queen'S University Belfast.
This section adds company-level context without repeating Stephen Wright's masked contact details.
AeroLeads found 1 current-domain work email signal for Stephen Wright. Compare company email patterns before reaching out.
Guiding the transfer of scientific innovation from the laboratory to the patient is my passion, and I have led internationally dispersed, cross-functional teams in the delivery of new treatment therapies to patients across the globe.I have a wealth of experience leading across the entire product lifecycle from manufacturing, development, and commercialization of products and have paved the path for multiple global approvals for Actemra across immunology and also as a viable treatment of patients with severe COVID-19. I’ve worked with scientific experts and senior leadership in steering teams toward the achievement of short- and long-range goals, stepping up to accelerate the study of therapies to address and meet the needs of an emerging pandemic.Since my early career days as a Clinical Scientist (Medical Director), I’ve worked hard to lead teams in global product development and acted as clinical lead for FDA, EMA< and ROW post submission regulatory interactions, gaining multiple global approvals for Actemra. Throughout the years, I’ve developed a robust portfolio of success stories —propelling innovation that has triggered revenue growth and favorably impacted the health and wellbeing of millions of patients.BUSINESS GROWTH: Drove growth >30%. Tactics included creating and executing the strategy needed to meet the demand triggered by a global pandemic.PEOPLE LEADERSHIP: An expert at building and synergizing high-performance teams, I set the course for excellence and then lead, coach, and mentor team members –ensuring everyone has the information, support, and tools necessary to succeed.PROJECT MANAGEMENT: Throughout my career, I have powered international teams, directing high value projects and programs. In addition, I have a reputation for delivering global development programs for both pediatric and adult diseases, including device development with multiple interactions with global regulatory agencies and filing submissions for original BLA, supplemental BLA and Type II variations and gaining biologic license and market authorization applications.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Switzerland 🇨🇭, CH
Stepped into a new role at Roche/GNE in response to COVID-19 and evolving data, revealing globally approved biologic therapy (Actemra) could help patients with severe COVID-19 pneumonia. Took the lead of an Executive level team to help steer a cross-functional team of ~500 people globally to progress novel studies through approval and market delivery in.
Switzerland 🇨🇭, CH
Strengthened global product strategy, leading, aligning, and mobilizing teams focused on immunology, ophthalmology, and infectious diseases to maximize sales potential, minimize time-to-market, and deliver financial returns. Led teams accountable for CHF 1.5b brand. Propelled the Frontiers of Healthcare: Served as a liaison, reporting to SVP of Global.
Switzerland 🇨🇭, CH
Steered global product development, immunology, ophthalmology, and infectious diseases as clinical head of late-stage development for Actemra in a direct report relationship to the SVP of Clinical Development. Additional accountabilities included serving as Development Review Committee Chair Delegate (responsible for all decision related to development.
Switzerland 🇨🇭, CH
Served as interim lifecycle leader, global product development, immunology, and infectious diseases. Headed cross-functional strategic teams. Set goals and initiated plans for annual lifecycles and maintained international partnerships. Successfully attained funding for phase III program in Systemic Sclerosis.
Switzerland 🇨🇭, CH
Continued to make a positive impact, leading to assignment as Global Development Team Leader for Actemra. Synchronized the efforts of global development teams in South San Francisco, New York, Welwyn, Basel, and Beijing. Implemented best practices to achieve program milestones in adult RA, pediatric arthritis, vasculitis, other rheumatic diseases, new.
Switzerland 🇨🇭, CH
Promoted to high-visibility and accountability leadership role overseeing global clinical program, Actemra subcutaneous (2 phase 3 studies and SC device development program). Provided clinical input, defining and implementing confirmatory development strategy across the entire life cycle for Actemra. Demonstrated influential and expert-level communication.
Switzerland 🇨🇭, CH
Began career at Roche as a lead clinical scientist with oversite of global pediatric clinical development program (Actemra IV Program). Mentored and directed scientists based in New Jersey and the UK. Served as clinical lead for FDA, EMA, and ROW post submissions and regulatory interactions, which resulted in the first global approval of IV Actemra in 2011.
Provided care to patients in the specialty of general rheumatology. Excelled at diagnosing and managing the care of patients with a wide range of conditions, including inflammatory autoimmune diseases. Prioritized the care of patients undergoing biologic therapies within this large academic teaching hospital known for its dedication to excellence in.
Interim Consulting Rheumatologist/Senior Lecturer at Queen’s University Belfast and Musgrave Park Hospital, Northern Ireland
Pediatric Rheumatology Training and Advanced Musculoskeletal Ultrasound Training, Royal Victoria Hospital, Belfast City Hospital, and Musgrave Park Hospital, Northern Ireland Deanery Training Rotation
Belfast, Antrim, GB
Strong research-based foundation in the department of therapeutics and pharmacology (Queen’s University Belfast, Northern Ireland). Awarded the first-ever "Welcome Trust Clinical Research Fellowship in Northern Ireland" and benefitted greatly from a 2-year research program: synthesizing the relationship between endothelial dysfunction, free radical.
Quick answers generated from the profile data available on this page.
Stephen Wright works for Roche.
Stephen Wright is listed as Senior Director Global Product Strategy & Franchise Lead for Rheumatology & Nephrology at Roche/Genentech at Roche.
AeroLeads has found 1 work email signal at @roche.com for Stephen Wright at Roche.
Stephen Wright is based in South San Francisco, California, United States while working with Roche.
Stephen Wright has worked for Roche, Addenbrookes Hospital Trust, Cambridge, Musculoskeletal Education And Research Unit, Queens University Belfast/Musgrave Park Hospital, Musgrave Park Hospital Belfast, and Queen'S University Belfast.
You can use AeroLeads to view verified contact signals for Stephen Wright at Roche, including work email, phone, and LinkedIn data when available.
Stephen Wright holds Doctor Of Medicine Md, Medicine from Queen'S University Belfast.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts